🔎 Trials Near Me

Akèy › Hidradénite suppurative › New York

Etid klinik pou Hidradénite suppurative nan New York

7 etid pou Hidradénite suppurative ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  • Cameron Dermatology, New York
  • Icahn School Of Med At Mount Sinai, New York
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT07665437

Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa

  • Clinical Site 5, New York
  • Clinical Site 4, The Bronx
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07828860

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

  • Equity Medical (LLC)- Site Number : 8400010, The Bronx
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07225569

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

  • Investigative Site US082, East Syracuse
  • Investigative Site US034, New York
  • Investigative Site US081, New York
  • ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06855498

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

  • Dr Bobby Buka, Md Greenwich Village, New York
  • Equity Medical, Llc, New York
Ap rekriteFaz 1
Laj 12 a 75 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049575

A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa

  • Equity Medical, LLC, The Bronx
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 22, 2026 · NCT07384975

A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

  • Northwell Health Physician Partners, Lake Success
  • Mount Sinai Doctors, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 6, 2026 · NCT07244263

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.